ResearcherKurume UniversityNo recent work listed
Tetsuro Sasada
Matched on ORCID iD 0000-0002-2313-8833; OpenAlex author ID A5000734437. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 3 papers
Papers 8
- Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.3390/biomedicines9101396↗
- High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer. Co-author DOI 10.3892/ijo.2020.5147↗
- Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer. Co-author DOI 10.3892/mco.2020.2201↗
- High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0226707↗
- High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer. Co-author DOI 10.3892/or.2020.7610↗
- Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer. Co-author DOI 10.18632/oncotarget.25837↗
- Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized P… Last author DOI 10.1155/2013/981717↗
- A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients. Last author DOI 10.3892/or.2013.2556↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Erica Yada · 5 shared papers, 2018–2021 · strength 0.47
- Paper Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/biomedicines9101396↗
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreat… DOI 10.18632/oncotarget.25837↗
- Satoshi Wada · 5 shared papers, 2018–2021 · strength 0.47
- Paper Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/biomedicines9101396↗
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreat… DOI 10.18632/oncotarget.25837↗
- Yutaro Kubota · 3 shared papers, 2020–2021 · strength 0.25
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in p… DOI 10.3892/or.2020.7610↗
- Paper High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. DOI 10.1371/journal.pone.0226707↗
- Ryotaro Ohkuma · 3 shared papers, 2020–2021 · strength 0.25
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in p… DOI 10.3892/or.2020.7610↗
- Paper High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. DOI 10.1371/journal.pone.0226707↗
- Tomoko Norose · 3 shared papers, 2020–2021 · strength 0.25
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in p… DOI 10.3892/or.2020.7610↗
- Paper High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. DOI 10.1371/journal.pone.0226707↗
- Shigeru Yutani · 3 shared papers, 2013–2021 · strength 0.20
- Paper Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic c… DOI 10.3892/mco.2020.2201↗
- Paper Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advance… DOI 10.1155/2013/981717↗
- Paper A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients. DOI 10.3892/or.2013.2556↗
- Yohei Miyagi · 1 shared paper, 2021 · strength 0.14
- Yoshihiro Uchino · 1 shared paper, 2021 · strength 0.13
- Hiroki Yamaue · 1 shared paper, 2018 · strength 0.08
- Hiroyuki Kuwano · 1 shared paper, 2018 · strength 0.08
- Seiko Hirono · 1 shared paper, 2018 · strength 0.08
- Mariko Tsukagoshi · 1 shared paper, 2018 · strength 0.08
- Ken Shirabe · 1 shared paper, 2018 · strength 0.08
- Koji Tamada · 1 shared paper, 2020 · strength 0.08
- Takehiko Yokobori · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.